Joel Greenblatt acquired 11.4 Thousand Regeneron Pharmaceuticals shares worth $6.03 Million. That's 0.06% of their equity portfolio (429th largest holding). The first Regeneron Pharmaceuticals trade was made in Q3 2013. Since then Joel Greenblatt bought shares seventeen more times and sold shares on 23 occasions. The stake costed the investor $5.71 Million, netting the investor a gain of 5.6% so far.